Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | GT | POET |
|---|---|---|
| Price | $4.68 | $7.81 |
| Change today | ▼ 3.31% | ▲ 0.26% |
| Market cap | $1.35B | $1.35B |
| Return, 3 months | -33.3% | -5.6% |
| Return, year to date | -46.6% | +23.4% |
| Return, 1 year | -38.1% | +22.4% |
| P/E (TTM) | -0.5 | -11.3 |
| P/B | 0.5 | 1.6 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 30 | 50 |
| 30-day volatility | 49.1% | 67.5% |
| Max drawdown, 1 year | -55.6% | -69.0% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
